Report cover image

Global Phage Therapy Competitive Landscape Professional Research Report 2025

Publisher DIResearch
Published Jan 23, 2025
Length 170 Pages
SKU # DIR19532300

Description

Global Phage Therapy Competitive Landscape Professional Research Report 2025



Research Summary

Phage therapy is a form of medical treatment that utilizes bacteriophages, which are viruses that infect and kill bacteria, to combat bacterial infections in humans or animals. Bacteriophages are highly specific to particular strains of bacteria, allowing for targeted and precise treatment. In phage therapy, specific phages are selected to match the infectious bacteria, and these phages are then administered to the patient, typically in the form of a phage cocktail. The phages infect and replicate within the bacterial cells, ultimately leading to the destruction of the bacteria. Phage therapy has been explored as an alternative or complementary approach to antibiotics, particularly in cases where antibiotic resistance poses a challenge. While phage therapy has shown promise, it is still an evolving field, and further research is needed to establish its safety and efficacy for widespread clinical use.

According to DIResearch's in-depth investigation and research, the global Phage Therapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Phage Therapy include BiomX (Adaptive Phage Therapeutics), Armata Pharmaceuticals, Phaxiam, Locus, Biosciences, Inc, TechnoPhage, NPO Microgen, MicroMir, Biochimpharm, iNtRON Biotechnology, PrecisioBiotix, Eliava BioPreparations, Intralytix, NexaBiome, CreatiPhage etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Phage Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Phage Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Phage Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Phage Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Phage Therapy Include:

BiomX (Adaptive Phage Therapeutics)

Armata Pharmaceuticals

Phaxiam

Locus

Biosciences, Inc

TechnoPhage

NPO Microgen

MicroMir

Biochimpharm

iNtRON Biotechnology

PrecisioBiotix

Eliava BioPreparations

Intralytix

NexaBiome

CreatiPhage

Phage Therapy Product Segment Include:

Natural Phages

Synthetic Phages

Phage Therapy Product Application Include:

Animal Health

Human Health

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Phage Therapy Industry PESTEL Analysis

Chapter 3: Global Phage Therapy Industry Porter’s Five Forces Analysis

Chapter 4: Global Phage Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Phage Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Phage Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Phage Therapy Market Overview
1.1 Product Definition and Statistical Scope
1.2 Phage Therapy Product by Type
1.2.1 Natural Phages
1.2.2 Synthetic Phages
1.3 Phage Therapy Product by Application
1.3.1 Animal Health
1.3.2 Human Health
1.4 Global Phage Therapy Market Size Analysis (2020-2032)
1.5 Phage Therapy Market Development Status and Trends
1.5.1 Phage Therapy Industry Development Status Analysis
1.5.2 Phage Therapy Industry Development Trends Analysis
2 Phage Therapy Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Phage Therapy Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Phage Therapy Market Analysis by Regions
4.1 Phage Therapy Overall Market: 2024 VS 2025 VS 2032
4.2 Global Phage Therapy Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Phage Therapy Revenue and Market Share by Region (2020-2025)
4.2.2 Global Phage Therapy Revenue Forecast by Region (2026-2032)
5 Global Phage Therapy Market Size by Type and Application
5.1 Global Phage Therapy Market Size by Type (2020-2032)
5.2 Global Phage Therapy Market Size by Application (2020-2032)
6 North America
6.1 North America Phage Therapy Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Phage Therapy Market Size by Type
6.4 North America Phage Therapy Market Size by Application
6.5 North America Phage Therapy Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Phage Therapy Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Phage Therapy Market Size by Type
7.4 Europe Phage Therapy Market Size by Application
7.5 Europe Phage Therapy Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Phage Therapy Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Phage Therapy Market Size by Type
8.4 China Phage Therapy Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Phage Therapy Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Phage Therapy Market Size by Type
9.4 APAC (excl. China) Phage Therapy Market Size by Application
9.5 APAC (excl. China) Phage Therapy Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Phage Therapy Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Phage Therapy Market Size by Type
10.4 Latin America Phage Therapy Market Size by Application
10.5 Latin America Phage Therapy Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Phage Therapy Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Phage Therapy Market Size by Type
11.4 Middle East & Africa Phage Therapy Market Size by Application
11.5 Middle East & Africa Phage Therapy Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Phage Therapy Market Revenue by Key Manufacturers (2021-2025)
12.2 Phage Therapy Competitive Landscape Analysis and Market Dynamic
12.2.1 Phage Therapy Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 BiomX (Adaptive Phage Therapeutics)
13.1.1 BiomX (Adaptive Phage Therapeutics) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 BiomX (Adaptive Phage Therapeutics) Phage Therapy Product Portfolio
13.1.3 BiomX (Adaptive Phage Therapeutics) Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Armata Pharmaceuticals
13.2.1 Armata Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Armata Pharmaceuticals Phage Therapy Product Portfolio
13.2.3 Armata Pharmaceuticals Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Phaxiam
13.3.1 Phaxiam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Phaxiam Phage Therapy Product Portfolio
13.3.3 Phaxiam Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 Locus
13.4.1 Locus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Locus Phage Therapy Product Portfolio
13.4.3 Locus Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Biosciences, Inc
13.5.1 Biosciences, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Biosciences, Inc Phage Therapy Product Portfolio
13.5.3 Biosciences, Inc Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 TechnoPhage
13.6.1 TechnoPhage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 TechnoPhage Phage Therapy Product Portfolio
13.6.3 TechnoPhage Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 NPO Microgen
13.7.1 NPO Microgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 NPO Microgen Phage Therapy Product Portfolio
13.7.3 NPO Microgen Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 MicroMir
13.8.1 MicroMir Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 MicroMir Phage Therapy Product Portfolio
13.8.3 MicroMir Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Biochimpharm
13.9.1 Biochimpharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Biochimpharm Phage Therapy Product Portfolio
13.9.3 Biochimpharm Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 iNtRON Biotechnology
13.10.1 iNtRON Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 iNtRON Biotechnology Phage Therapy Product Portfolio
13.10.3 iNtRON Biotechnology Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 PrecisioBiotix
13.11.1 PrecisioBiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 PrecisioBiotix Phage Therapy Product Portfolio
13.11.3 PrecisioBiotix Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.12 Eliava BioPreparations
13.12.1 Eliava BioPreparations Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Eliava BioPreparations Phage Therapy Product Portfolio
13.12.3 Eliava BioPreparations Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.13 Intralytix
13.13.1 Intralytix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Intralytix Phage Therapy Product Portfolio
13.13.3 Intralytix Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.14 NexaBiome
13.14.1 NexaBiome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 NexaBiome Phage Therapy Product Portfolio
13.14.3 NexaBiome Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.15 CreatiPhage
13.15.1 CreatiPhage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.15.2 CreatiPhage Phage Therapy Product Portfolio
13.15.3 CreatiPhage Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Phage Therapy Industry Chain Analysis
14.2 Phage Therapy Industry Raw Material and Suppliers Analysis
14.2.1 Phage Therapy Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Phage Therapy Typical Downstream Customers
14.4 Phage Therapy Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us